EAM
PMN icon

Empery Asset Management’s ProMIS Neurosciences PMN Stock Holding History

Empery Asset Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$766K Buy
+60,353
New +$900K 0.92% 14

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM

Empery Asset Management's PMN Position: Q1 2026 in Review

Empery Asset Management opened a new position in ProMIS Neurosciences (PMN) in Q1 2026: 60,353 shares worth $766K. The stake represents 0.92% of the portfolio and ranks #14 among its holdings.

25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Empery Asset Management held 60,353 shares of ProMIS Neurosciences worth $766K as of Q1 2026.
  • ProMIS Neurosciences was a new Empery Asset Management position in Q1 2026.
  • ProMIS Neurosciences made up 0.92% of Empery Asset Management's portfolio in Q1 2026, its #14 holding.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Empery Asset Management's 13F filing for Q1 2026, filed 8 May 2026.